Provectus Biopharmaceuticals Reports Third Quarter 2016 Financial Results

Autor: Provectus Biopharmaceuticals, Inc.
Zdroj: Business Wire (English). 11/10/2016.
Abstrakt: Provectus Biopharmaceuticals, Inc. (OTCQB:PVCT, www.provectusbio.com), a clinical-stage oncology and dermatology biopharmaceutical company ("Provectus" or the "Company”), today announced its financial results for the quarter ended September 30, 2016. [ABSTRACT FROM PUBLISHER]
Databáze: Regional Business News
Nepřihlášeným uživatelům se plný text nezobrazuje